CancerNavigator, Inc. — SEC Form D Filing

CancerNavigator, Inc. filed an SEC Form D on February 24, 2026, reporting $7.00M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
February 24, 2026
Amount reported
$7.00M
Round stage
Seed
Industry
Health Care
Website
https://www.cancernavigator.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many cancer patients struggle to find the right expert care after diagnosis, which can lead to poor health outcomes.

Solution

CancerNavigator provides dedicated support through certified oncology nurses who guide patients to the best care options for their specific cancer type.

Why now

The need for effective cancer navigation is pressing as a significant percentage of patients do not connect with appropriate specialists.

Verdict

This cleared because investors recognized the pressing need for personalized cancer care navigation, not because the competitive landscape was well-defined. The implicit bet was on the company’s ability to provide differentiated patient support via certified oncology nurses, which could potentially disrupt existing healthcare delivery models. However, the limited upside lies in the dependency on health plan executives, whose budgeting constraints might restrict growth and scalability over time.

Source: SEC EDGAR Form D filing